Plus Therapeutics Inc (PSTV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2005 | 12-2004 | 12-2003 | 12-2002 | 12-2001 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -26,538 | -2,090 | -9,283 | -13,003 | -11,207 |
| Depreciation Amortization | 1,724 | 824 | -389 | 1,204 | 1,184 |
| Accounts receivable | 46 | 472 | -53 | -775 | 230 |
| Other Working Capital | 24,329 | 2,127 | 996 | -1,422 | -1,290 |
| Other Operating Activity | -662 | -13,907 | 1,484 | 7,110 | 2,761 |
| Operating Cash Flow | $-1,101 | $-12,574 | $-7,245 | $-6,886 | $-8,322 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 2,757 | 811 | 8,294 | 11,185 | 5,927 |
| PPE Investments | -1,846 | 12,642 | -1,648 | 8,976 | -2,664 |
| Net Acquisitions | N/A | -28 | -654 | -2,896 | N/A |
| Purchase Of Investment | N/A | N/A | N/A | N/A | -1,000 |
| Other Investing Activity | 0 | 0 | -38 | 0 | 0 |
| Investing Cash Flow | $911 | $13,425 | $5,954 | $17,265 | $2,263 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 1,380 | 1,039 | 1,120 | N/A | 2,433 |
| Debt Repayment | -936 | -847 | -426 | -1,422 | -201 |
| Common Stock Issued | 4,913 | 29 | 575 | 893 | 128 |
| Common Stock Repurchased | N/A | -1,052 | -2,266 | -7,442 | -1,077 |
| Financing Cash Flow | $5,357 | $-831 | $-997 | $-7,971 | $1,283 |
| Beginning Cash Position | 2,840 | 2,820 | 5,108 | 2,700 | 7,476 |
| End Cash Position | 8,007 | 2,840 | 2,820 | 5,108 | 2,700 |
| Net Cash Flow | $5,167 | $20 | $-2,288 | $2,408 | $-4,776 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,101 | -12,574 | -7,245 | -6,886 | -8,322 |
| Capital Expenditure | -1,846 | -789 | -1,743 | -909 | -2,664 |
| Free Cash Flow | -2,947 | -13,363 | -8,988 | -7,795 | -10,986 |